Biology subjects

Newell, C.

Publications and source records attributed to Newell, C..

3 recordsLinked to original sources

bioRxiv2026

Inositol Polyphosphate-4-Phosphatase Type II promotes gemcitabine resistance in pancreatic ductal adenocarcinoma cells via lysosomal exocytosis

Chemotherapy resistance is a major challenge in pancreatic ductal adenocarcinoma (PDAC). While high Inositol Polyphosphate-4-Phosphatase Type II (INPP4B) expression correlates with poor outcomes, its function in chemotherapy response is unclear. We show that INPP4B promotes gemcitabine resistance by enhancing lysosomal exocytosis. Across PDAC models, high INPP4B linked to reduced gemcitabine sensitivity, while knockdown restored it. INPP4B also conferred cross-resistance to agents including irinotecan, oxaliplatin, paclitaxel, and daunorubicin. Mechanistically, INPP4B increased cell-surface LAMP1, enhanced extracellular gemcitabine release, and mitigated DNA damage. Pharmacological targeting of lysosomes with chloroquine (CQ), Bafilomycin A (BafA), or specific PIKfyve or TRPML1 inhibitors blocked exocytosis and reversed resistance in vitro. Moreover, chloroquine co-treatment restored gemcitabine sensitivity in INPP4B-overexpressing xenografts. These results establish INPP4B-driven lysosomal exocytosis as a key mechanism of gemcitabine resistance, highlighting a therapeutic target for PDAC resensitization.

cancer biology↗

bioRxiv2026

Programmable and Dynamic DNA Localisation at Synthetic Cell Membranes

Spatial and temporal organisation of membrane-associated components is fundamental to cellular signalling, yet remains difficult to engineer in minimal synthetic systems. In synthetic cells, DNA and RNA nanotechnology offer programmable molecular organisation at membranes, while in vitro transcription (IVT) enables gene expression-driven regulation. However, integrating these systems within cell-like compartments, such as giant unilamellar vesicles (GUVs), remains challenging due to undesirable interactions between transcription machinery and nucleic acid assemblies. Here, we present a modular strategy that couples in situ RNA production to dynamic DNA localisation at GUV synthetic cell membranes. RNA strands, transcribed within GUVs, function as linkers that recruit DNA-conjugated cargo to lipid membranes, enabling programmable spatial organisation. Using this framework, we achieved reversible membrane localisation through toehold-mediated strand displacement and RNase H-mediated degradation. This work establishes a gene expression-driven platform for programmable and dynamic control of membrane-associated components in synthetic cells, providing a foundation for constructing dynamic signalling assemblies and higher-order cellular behaviours. O_FIG O_LINKSMALLFIG WIDTH=191 HEIGHT=200 SRC="FIGDIR/small/738173v1_ufig1.gif" ALT="Figure 1"> View larger version (58K): org.highwire.dtl.DTLVardef@1d6dbc4org.highwire.dtl.DTLVardef@f6419aorg.highwire.dtl.DTLVardef@14cff99org.highwire.dtl.DTLVardef@20b95a_HPS_FORMAT_FIGEXP M_FIG C_FIG

synthetic biology↗

bioRxiv2024

Magnetic Activation of Spherical Nucleic Acids for the Remote Control of Synthetic Cells

The advancement of synthetic cells as drug delivery devices hinges on the development of targeting strategies, in particular the controlled synthesis of biomolecules in-situ using a deeply penetrative stimulus. To address this, we have designed spherical nucleic acids comprising DNA promoter sequences decorating magnetic nanoparticle cores. By harnessing the heat dissipated from magnetic hyperthermia (a clinically-approved anticancer therapy) we tightly controlled cell-free protein synthesis. We then deployed a tissue phantom that is impenetrable by current activation methods to demonstrate the potential of this technology for the remote control of synthetic cells using deeply tissue-penetrating magnetic fields. This paves the way for targeting and controlling the in-situ synthesis of biomolecules deep within the body. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=181 SRC="FIGDIR/small/608917v1_ufig1.gif" ALT="Figure 1"> View larger version (46K): org.highwire.dtl.DTLVardef@3cf352org.highwire.dtl.DTLVardef@18a8da3org.highwire.dtl.DTLVardef@159018aorg.highwire.dtl.DTLVardef@744529_HPS_FORMAT_FIGEXP M_FIG C_FIG

synthetic biology↗